United States Food and Drug Administration. Similar articles in PubMed. Prescribing for children without access to full prescribing information is often necessary. Epub Mar 1. In , the FDA approved fostamatinib, a spleen tyrosine kinase Syk inhibitor, as an option for patients whose disease is refractory to second-line treatments.
nest...